News

Review Case Discussions 'New horizons improving gold standard therapy in acute stroke'

Watch the records and read the summary report of the last EVER webinar!
read more

Cognitive Impairment? Cerebrolysin® helps!

Start with treatment as soon as you have the first signs!
read more
1 … 33 34 35 36 37 … 72
16.09.2025

Follow-up on NTSC Extended – 1st Thailand Edition

Bangkok, Thailand – July 3, 2025
Read more
20.08.2025

New video about ESCAS

Cerebrolysin® helps aphasia patients after Stroke
Read more
26.06.2025

Cerebrolysin® as an Adjunct Therapy to Mechanical Thrombectomy

New Study highlights Cerebrolysin's potential in improving longterm outcome
Read more
1 … 33 34 35 36
Go to Archive

Congresses

11th European Stroke Organisation Conference

Helsinki, Finland
21 - 23 May 2025
GO TO EVENT

17th World Stroke Congress

Barcelona, Spain
22 - 25 October 2025
GO TO EVENT

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.